U.S. FDA Accepts for Review the Biologics License Application for Pfizer's Investigational Pentavalent Meningococcal Vaccine Candidate (MenABCWY) in AdolescentsBusiness Wire • 12/28/22
Everest Medicines' Licensing Partner Pfizer Announces FDA and EMA Acceptance of Etrasimod Regulatory Submissions for Ulcerative ColitisPRNewsWire • 12/22/22
Pfizer Announces FDA and EMA Acceptance of Etrasimod Regulatory Submissions for Ulcerative ColitisBusiness Wire • 12/21/22
Pfizer Invites Public to View and Listen to Webcast of January 31 Conference Call with AnalystsBusiness Wire • 12/20/22
Pfizer gains rights to experimental RSV treatment in China, Hong Kong, Macau and SingaporeMarket Watch • 12/19/22